NCT07315048

Brief Summary

The investigators are testing whether a new nurse-led safety program (HFMEA) lowers problems during emergency brain-aneurysm surgery better than usual care. Adults with a sudden brain bleed (subarachnoid hemorrhage) who need urgent clipping or coil placement at the hospital are randomly placed in one of two groups: Usual nursing care, or Usual care plus HFMEA (nurses use checklists to spot and prevent risks such as re-bleeding, high brain pressure, infection, seizures). The investigators count how often any nursing-related problems happen within 30 days after surgery, how long patients stay, and how satisfied the participants and their families are. Results will show if this extra safety program should become standard practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

2.1 years

First QC Date

December 8, 2025

Last Update Submit

December 18, 2025

Conditions

Keywords

Healthcare Failure Mode and Effect AnalysisNursing Risk ManagementEmergency SurgeryPatient Safety

Outcome Measures

Primary Outcomes (1)

  • perioperative nursing adverse event

    Incidence of perioperative nursing adverse events, including: * Rebleeding * Cerebral vasospasm * Increased intracranial pressure * Seizures * Pulmonary infection * Pressure ulcers * Deep vein thrombosis * Catheter-related infections * Falls/bed exits * Medication errors, etc.

    30 days

Secondary Outcomes (5)

  • Nursing Quality Score

    30 days

  • Patient Satisfaction Score

    30 days

  • Family Satisfaction Degree

    30 days

  • Length of Hospital Stay

    30 days

  • 30-day Mortality

    30 days

Study Arms (2)

Intervention group

EXPERIMENTAL

Patients assigned to the intervention arm received every element of conventional emergency neurosurgical care plus a structured, prospective safety overlay derived from Healthcare Failure Mode and Effect Analysis. The add-on programme was delivered by a nine-member, hospital-authorised HFMEA team (one chief neurosurgeon, two attending neurosurgeons, one head nurse, four bedside nurses, one quality-manager) who had completed an 8-hour training course on HFMEA principles, risk-priority-number (RPN) scoring and decision-tree analysis. The programme ran from the minute the participant arrived in the emergency department until 30-days post-operation and consisted of six sequential steps that were re-applied every month.

Behavioral: HFMEA-based nursing-risk programme

Control group

NO INTERVENTION

The control group received conventional nursing risk management, including: 1. Admission assessment: vital signs monitoring, neurological function assessment, Hunt-Hess grading; 2. Preoperative nursing: condition observation, psychological care, preoperative preparation; 3. Postoperative nursing: close monitoring of vital signs, neurological function observation, complication prevention; 4. Health education: disease knowledge, precautions, rehabilitation guidance; 5. Discharge guidance: medication instructions, follow-up arrangements, lifestyle recommendations.

Interventions

Alongside standard care, these patients were managed with an HFMEA-based safety bundle. A trained nine-member team had pre-identified 12 highest-risk failure points (delayed ICP checks, missed re-bleeding signs, vasospasm, seizures, infection, etc.). From admission to day-30, nurses followed printed checklists and electronic order-sets: neuro-vitals every 15-30 min, BP target 140-160 mmHg, daily TCDs, automatic "red-flag" escalation for sudden headache/GCS drop, Triple-H protocol for velocities \>120 cm/s, prophylactic levetiracetam for severe grades, 30° head positioning, chlorhexidine/line bundles, pain-delirium scale, bed-alarm, SBAR hand-over and a 5-minute family video with teach-back. Compliance was tracked in real time and reviewed monthly; measures were updated if failure rates did not fall within six weeks.

Intervention group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • sSAH confirmed by head CT and/or CT angiography (CTA) or digital subtraction angiography (DSA), with identified intracranial aneurysm;
  • Age 18-75 years;
  • Time from onset to admission ≤72 hours;
  • Undergoing emergency surgical treatment (open aneurysm clipping or endovascular coiling);
  • Hunt-Hess grade I-V;
  • Patient or family consent to participate in the study with signed informed consent.

You may not qualify if:

  • Traumatic subarachnoid hemorrhage;
  • Concurrent other intracranial diseases (e.g., brain tumors, arteriovenous malformations);
  • Severe cardiac, hepatic, or renal dysfunction;
  • Coagulation disorders;
  • History of psychiatric disorders or cognitive impairment;
  • Pregnancy or lactation;
  • Transfer to another hospital or treatment withdrawal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Location

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 8, 2025

First Posted

January 2, 2026

Study Start

March 1, 2022

Primary Completion

March 30, 2024

Study Completion

April 1, 2024

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations